- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00512824
Calcium, Probiotics and Acute Diarrheal Disease Among Indonesian Children
January 7, 2011 updated by: Wageningen University
Calcium, Probiotics and Acute Diarrheal Disease Among Indonesian Children Aged 1-6 Years in Low Socio-economic Urban Area of East Jakarta
This is a long term study on the efficacy of dietary calcium with or without probiotic strains in reducing the mean number of episodes and duration of diarrheal disease.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
494
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jakarta, Indonesia, 10430
- Seameo-Tropmed Rccn Ui
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 6 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Apparently healthy children aged 1-6 years, with emphasize on aged 2-5 years, living permanently in low socio-economic urban areas of East Jakarta for at least 6 months
- Parents are willing to sign the informed consent and give the supplements to the children for the period of 6 months
- Capable and willing to drink liquid milk with a straw (acceptance to be tested at screening by providing a sample drink and placebo straw to be consumed under supervision for 2 days)
Exclusion Criteria:
- Calcium intake exceeding 75% of the RDA for calcium (<375 mg/d) based on a Food Frequency Questionnaire
- Currently breastfed children
- Siblings of already included children that are living in the same household, except if it is a twin sibling
- Severely malnourished with or without oedema (Weight for height-WHZ Z-score of <-3.00 SD)
- Symptoms of chronic/congenital diseases and disabilities, suspected Tuberculosis by clinical examination, and /or history of allergic disease.
- Taking (any) antibiotics during 2 weeks prior to start of the study (children will be included after 3 weeks of last antibiotic intake
- Participation in another clinical trial at the same time or 2 months prior to the start of this study
- Both mothers and other caregivers present in the family are illiterate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 2
|
twice daily for 24 weeks
|
|
Placebo Comparator: 1
|
twice daily for 24 weeks
|
|
Active Comparator: 3
|
twice daily for 24 weeks
|
|
Active Comparator: 4
|
twice daily for 24 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The mean number of episodes and duration of acute diarrheal disease
Time Frame: 24 weeks
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of acute diarrheal disease
Time Frame: 24 weeks
|
24 weeks
|
|
Severity of acute diarrheal disease
Time Frame: 24 weeks
|
24 weeks
|
|
Intestinal and systemic inflammation
Time Frame: 24 weeks
|
24 weeks
|
|
Intestinal colonization with pathogenic bacteria or viruses
Time Frame: 24 weeks
|
24 weeks
|
|
Nutritional status based on anthropometric measurement
Time Frame: 24 weeks
|
24 weeks
|
|
Iron and zinc status
Time Frame: 24 weeks
|
24 weeks
|
|
Incidence, mean episodes and duration of acute respiratory infections
Time Frame: 24 weeks
|
24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rina Agustina, MD, Seameo-Tropmed Rccn Ui
- Study Chair: Frans J. Kok, Prof, Division of Human Nutrition, Wageningen University (WUR)
- Study Director: Ingeborg Bovee-Oudenhoven, PhD, TIFN/ NIZO Food Research
- Study Chair: Agus Firmansyah, Prof, MD, Faculty of Medicine University of Indonesia
- Study Director: Widjaja Lukito, MD, Seameo-Tropmed Rccn Ui
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Agustina R, Bovee-Oudenhoven IM, Lukito W, Fahmida U, van de Rest O, Zimmermann MB, Firmansyah A, Wulanti R, Albers R, van den Heuvel EG, Kok FJ. Probiotics Lactobacillus reuteri DSM 17938 and Lactobacillus casei CRL 431 modestly increase growth, but not iron and zinc status, among Indonesian children aged 1-6 years. J Nutr. 2013 Jul;143(7):1184-93. doi: 10.3945/jn.112.166397. Epub 2013 May 22.
- Agustina R, Kok FJ, van de Rest O, Fahmida U, Firmansyah A, Lukito W, Feskens EJ, van den Heuvel EG, Albers R, Bovee-Oudenhoven IM. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics. 2012 May;129(5):e1155-64. doi: 10.1542/peds.2011-1379. Epub 2012 Apr 9.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2007
Primary Completion (Actual)
September 1, 2008
Study Completion (Actual)
September 1, 2008
Study Registration Dates
First Submitted
August 6, 2007
First Submitted That Met QC Criteria
August 7, 2007
First Posted (Estimate)
August 8, 2007
Study Record Updates
Last Update Posted (Estimate)
January 10, 2011
Last Update Submitted That Met QC Criteria
January 7, 2011
Last Verified
January 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A011-CPDI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
University Hospital, Strasbourg, FranceICube LaboratoryNot yet recruitingHealthy | Healthy AdultFrance
-
Beijing Tide Pharmaceutical Co., LtdRecruitingHealthy | Healthy ParticipantsChina
Clinical Trials on low calcium milk of 180 ml
-
Chinese PLA General HospitalCompletedCoronary Artery DiseaseChina
-
Indonesia UniversityWageningen University; SEAMEO Regional Centre for Food and NutritionCompletedDepression | Obesity | Insulin Resistance | Dyslipidemias | Behavior | Stunting | Cognitive Function 1, Social | Permeability; IncreasedIndonesia
-
Dawid MadejRecruiting
-
Instituto Nacional de Salud Publica, MexicoCompletedCardiovascular DiseasesMexico
-
Frank LippertThe Borrow FoundationCompleted
-
Dompé Farmaceutici S.p.ACompleted
-
Dompé Farmaceutici S.p.ACovanceCompletedHealthySwitzerland, United Kingdom
-
Haseki Training and Research HospitalCompletedAtrial Fibrillation | Hypotension Drug-Induced | Rapid Ventricular ResponseTurkey
-
Federico II UniversityUnknownHypertension | Body WeightItaly
-
Laval UniversityDairy Farmers of Canada; National Dairy CouncilCompleted